These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7853803)

  • 1. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD.
    Zemel D; Imholz AL; de Waart DR; Dinkla C; Struijk DG; Krediet RT
    Kidney Int; 1994 Nov; 46(5):1422-30. PubMed ID: 7853803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
    Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT
    Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
    Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
    Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
    Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
    Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.
    Pereira BJ; Shapiro L; King AJ; Falagas ME; Strom JA; Dinarello CA
    Kidney Int; 1994 Mar; 45(3):890-6. PubMed ID: 8196293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis.
    Lu Y; Hylander B; Brauner A
    Perit Dial Int; 1996; 16(6):607-12. PubMed ID: 8981529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle.
    Jörres A; Topley N; Steenweg L; Müller C; Köttgen E; Gahl GM
    Am J Nephrol; 1992; 12(1-2):80-5. PubMed ID: 1415370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
    Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
    Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired initial cell reaction in CAPD-related peritonitis.
    Koopmans JG; Boeschoten EW; Pannekeet MM; Betjes MG; Zemel D; Kuijper EJ; Krediet RT
    Perit Dial Int; 1996; 16 Suppl 1():S362-7. PubMed ID: 8728224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.
    Zemel D; ten Berge RJ; Struijk DG; Bloemena E; Koomen GC; Krediet RT
    Clin Nephrol; 1992 Feb; 37(2):97-103. PubMed ID: 1551256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.